Magnetar Financial’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-977
Closed -$469K 1351
2026
Q1
$469K Sell
977
-1,641
-63% -$840K ﹤0.01% 649
2025
Q4
$1.47M Buy
+2,618
New +$1.49M 0.01% 386
2025
Q2
Sell
-8,749
Closed -$2.67M 1036
2025
Q1
$2.67M Buy
+8,749
New +$2.94M 0.04% 248
2021
Q1
Sell
-2,673
Closed -$372K 1140
2020
Q4
$372K Buy
+2,673
New +$337K 0.01% 601
2020
Q1
Sell
-10,269
Closed -$863K 568
2019
Q4
$863K Buy
+10,269
New +$795K 0.02% 239
2018
Q1
Sell
-6,867
Closed -$249K 710
2017
Q4
$249K Buy
+6,867
New +$241K ﹤0.01% 563
2017
Q2
Sell
-7,322
Closed -$219K 903
2017
Q1
$219K Buy
+7,322
New +$236K ﹤0.01% 657

Other funds holding MEDP

Magnetar Financial's MEDP Position: Q2 2026 in Review

Magnetar Financial sold out of Medpace (MEDP) in Q2 2026, closing a stake of 977 shares — an estimated $469K sold.

Magnetar Financial first reported a position in MEDP in Q1 2017 and held it in 7 quarters. The position peaked at $2.67M in Q1 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Magnetar Financial reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Magnetar Financial sold 977 Medpace shares in Q2 2026, an estimated $469K.
  • Magnetar Financial first reported a position in Medpace in Q1 2017 and held it in 7 quarters.
  • Magnetar Financial's Medpace position peaked at $2.67M in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.